Cefpodoxime Proxetil Dispersible Tablets 100mg
Cefpodoxime Proxetil 100mg Dispersible Tablet — same oral third-generation cephalosporin prodrug mechanism as PODROCK™ Drops, 50, and 100 dry syrup (PBP binding, cell wall synthesis inhibition, extended MSSA coverage). The dispersible tablet format at 100mg provides a solid-form alternative to liquid suspensions for children above 5 years and adults requiring sub-200mg dosing, without the refrigeration requirements of reconstituted suspensions.
Acute otitis media, pharyngitis, tonsillitis, acute sinusitis, community-acquired pneumonia, UTI, uncomplicated gonorrhoea, and MSSA skin infections in older children (above 5 years) and adults. The dispersible format is particularly valuable as a transition formulation from paediatric syrups and for adults with dysphagia.
Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.
PODROCK™ 100 DT completes the PODROCK™ range by providing a solid dispersible formulation alongside the liquid drops and dry syrups — covering patients from the earliest infancy through adulthood within a single brand. The dispersible format is particularly practical in the 5–12 year age group transitioning away from liquids but not yet reliable tablet-swallowers, a clinical phase where dispersible solid formulations dramatically improve administration reliability.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.